EFFICACY AND SAFETY OF AGOMELATINE (25-50 MG/DAY) VERSUS ESCITALOPRAM (10-20 MG/DAY) IN SEVERE GENERALIZED ANXIETY DISORDER Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Stein, D
  • Khoo, J-P
  • Van Ameringen, Michael
  • Hoschl, C
  • Ahokas, A
  • Bauer, M
  • Bitter, I
  • Jarema, M
  • Mosolov, SN
  • Vavrusova, L
  • Picarel-Blanchot, F
  • Olivier, V
  • de Bodinat, C

publication date

  • April 1, 2018